Concepts for the clinical use of stem cells in equine medicine

Canadian Veterinary Journal

Volumn 49, Issue 10, 2008, Pages 1009-1017

  Koch, Thomas G ^a,b   Berg, Lise C ^b   Betts, Dean H ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; CELL DIFFERENTIATION; HORSE; HORSE DISEASE; PHYSIOLOGY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; CELL DIFFERENTIATION; HORSE DISEASES; HORSES; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EQUIDAE;

EID: 54249113320     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
2. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
3. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A 1995;92:7844-7848.
4. Li X, Zhou SG, Imreh MP, Abrlund-Richter L, Allen WR. Horse embryonic stem cell lines from the proliferation of inner cell mass cells. Stem Cells Dev 2006;15:523-531.
5. Saito S, Sawai K, Minamihashi A, Ugai H, Murata T, Yokoyama KK. Derivation, maintenance, and induction of the differentiation in vitro of equine embryonic stem cells. Methods Mol Biol 2006;329:59-79.
6. Saito S, Ugai H, Sawai K, et al. Isolation of embryonic stem-like cells from equine blastocysts; and their differentiation in vitro. FEBS Lett 2002;531:389-396.
7. Saito S, Yokoyama K, Tamagawa T, Ishiwata I. Derivation and induction of the differentiation of animal ES cells as well as human pluripotent stem cells derived from fetal membrane. Hum Cell 2005;18: 135-141.
8. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 2003;35:99-102.
9. Carstanjen B, Desbois C, Hekmati M, Behr L. Successful engraftment of cultured autologous mesenchymal stem cells in a surgically repaired soft palate defect in an adult horse. Can J Vet Res 2006;70:143-147.
10. Fortier LA, Nixon AJ. New surgical treatments for osteochondritis dissecans and subchondral bone cysts. Vet Clin North Am Equine Pract 2005;21:673-690.
11. Koch TG, Heerkens T, Thomsen PD, Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 2007;7:26.
12. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001;19:193-204.
13. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
14. Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005;85:635-678.
15. Xu RH, Chen X, Li DS, et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 2002;20: 1261-1264.
16. Xu RH. In vitro induction of trophoblast from human embryonic stem cells. Methods Mol Med 2006;121:189-202.
17. Cai J, Weiss ML, Rao MS. In search of "stemness." Exp Hematol 2004;32:585-598.
18. Pyle AD, Donovan PJ, Lock LF. Chipping away at 'stemness'. Genome Biol 2004;5:235 (5 pp.).
19. Marion NW, Mao JJ. Mesenchymal stem cells and tissue engineering. Methods Enzymol 2006;420:339-361.
20. Tyndall A, Walker UA, Cope A, et al. Immunomodulatory properties of mesenchymal stem cells: A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 2007;9:301 (10 pp.).
21. Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004;200:123-135.
22. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
23. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-395.
24. Fletcher JM, Ferrier PM, Gardner JO, et al. Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines. Cloning Stem Cells 2006;8:319-334.
25. Amit M, Itskovitz-Eldor J. Feeder-free culture of human embryonic stem cells. Methods Enzymol 2006;420:37-49.
26. Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R. Human embryonic stem cells derived without feeder cells. Lancet 2005;365:1636-1641.
27. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R. Human embryonic stem cell lines derived from single blastomeres. Nature 2006;444:481-485.
28. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
29. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317.
30. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448: 318-324.
31. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004;22:625-634.
32. Fortier LA, Nixon AJ, Williams J, Cable CS. Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 1998;59:1182-1187.
33. Hauner H, Entenmann G, Wabitsch M, et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989;84:1663-1670.
34. Kang YJ, Jeon ES, Song HY, et al. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 2005;95: 1135-1145.
35. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003;183:355-366.
36. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002;297:2256-2259.
37. Chen KA, Laywell ED, Marshall G, Walton N, Zheng T, Steindler DA. Fusion of neural stem cells in culture. Exp Neurol 2006;198:129-135.
38. Filip S, Mokry J, English D, Vojacek J. Stem cell plasticity and issues of stem cell therapy. Folia Biol (Praha) 2005;51:180-187.
39. Vieyra DS, Jackson KA, Goodell MA. Plasticity and tissue regenerative potential of bone marrow-derived cells. Stem Cell Rev 2005;1: 65-69.
40. Milstein C. The hybridoma revolution: An offshoot of basic research. Bioessays 1999;21:966-973.
41. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004;116: 639-648.
42. Hofmeister CC, Zhang J, Knight KL, Le P, Stiff PJ. Ex vivo expansion of umbilical cord blood stem cells for transplantation: Growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007;39:11-23.
43. Nilsson SK, Simmons PJ. Transplantable stem cells: Home to specific niches. Curr Opin Hematol 2004;11:102-106.
44. Ema H, Nakauchi H. "Homing to Niche," a new criterion for hematopoietic stem cells? Immunity 2004;20:1-2.
45. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813-1826.
46. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-1301.
47. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084.
48. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
49. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
50. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2005;2(July 26):8.
51. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48.
52. Ringden O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81:1390-1397.
53. Ringden O. Immunotherapy by allogeneic stem cell transplantation. Adv Cancer Res 2007;97C:25-60.
54. Le Blanc K, Ringden O. Mesenchymal stem cells: Properties and role in clinical bone marrow transplantation. Curr Opin Immunol 2006;18:586-591.
55. Rasmusson I, Le Blanc K, Sundberg B, Ringden O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 2007;65:336-343.
56. Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006;107:367-372.
57. Menendez P, Bueno C, Wang L, Bhatia M. Human embryonic stem cells: Potential tool for achieving immunotolerance? Stem Cell Rev 2005;1:151-158.
58. Han ZM, Chen DY, Li JS, et al. Mitochondrial DNA heteroplasmy in calves cloned by using adult somatic cell. Mol Reprod Dev 2004;67:207-214.
59. Inoue K, Ogonuki N, Yamamoto Y, et al. Tissue-specific distribution of donor mitochondrial DNA in cloned mice produced by somatic cell nuclear transfer. Genesis 2004;39:79-83.
60. Martin MJ, Yin D, Adams C, et al. Skin graft survival in genetically identical cloned pigs. Cloning Stem Cells 2003;5:117-121.
61. Cui JH, Park K, Park SR, Min BH. Effects of low-intensity ultrasound on chondrogenic differentiation of mesenchymal stem cells embedded in polyglycolic acid: An in vivo study. Tissue Eng 2006;12:75-82.
62. Huang CY, Hagar KL, Frost LE, Sun Y, Cheung HS. Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells 2004;22:313-323.
63. Miyanishi K, Trindade MC, Lindsey DP, et al. Dose- and time-dependent effects of cyclic hydrostatic pressure on transforming growth factor-beta3-induced chondrogenesis by adult human mesenchymal stem cells in vitro. Tissue Eng 2006;12:2253-2262.
64. Caplan AI, Bruder SP. Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 2001; 7:259-264.
65. Poh KK, Sperry E, Young RG, Freyman T, Barringhaus KG, Thompson CA. Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: Safety of a high dose, "off-the-shelf," cellular cardiomyoplasty strategy. Int J Cardiol 2007;117:360-364.
66. Narayan AD, Chase JL, Lewis RL, et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 2006;107:2180-2183.
67. Almeida-Porada G, Zanjani ED. A large animal noninjury model for study of human stem cell plasticity. Blood Cells Mol Dis 2004; 32:77-81.
68. Zanjani ED, Pallavicini MG, Ascensao JL, et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 1992;89:1178-1188.
69. Liechty KW, MacKenzie TC, Shaaban AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature medicine 2000;6:1282-1286.
70. Kisiday JD, Kopesky PW, Evans CH, Grodzinsky AJ, McIlwraith CW, Frisbie DD. Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 2008;26:322-331.
71. Wilke MM, Nydam DV, Nixon AJ. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007;25:913-925.
72. Pacini S, Spinabella S, Trombi L, et al. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue engineering 2007;13:2949-2955.
73. Crovace A, Lacitignola L, De Siena R, Rossi G, Francioso E. Cell therapy for tendon repair in horses: An experimental study. Veterinary research communications 2007;31:281-283.
74. Fortier LA, Smith RK. Regenerative medicine for tendinous and ligamentous injuries of sport horses. Vet Clin North Am Equine Pract 2008;24:191-201.
75. Richardson LE, Dudhia J, Clegg PD, Smith R. Stem cells in veterinary medicine - attempts at regenerating equine tendon after injury. Trends in biotechnology 2007;25:409-416.
76. Taylor SE, Smith RK, Clegg PD. Mesenchymal stem cell therapy in equine musculoskeletal disease: Scientific fact or clinical fiction? Equine Vet J 2007;39:172-180.
77. Koch TG, Betts DH. Stem cell therapy for joint problems using the horse as a clinically relevant animal model. Expert opinion on biological therapy 2007;7:1621-1626.
78. Maitra B, Szekely E, Gjini K, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004;33:597-604.
79. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: The IACT Study. J Am Coll Cardiol 2005;46:1651-1658.
80. Bartsch T, Brehm M, Zeus T, Strauer BE. Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease. J Cardiovasc Nuts 2006;21:430-432.
81. Lu CW, Hung Y, Hsiao JK, et al. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 2007;7:149-154.
82. Partlow KC, Chen J, Brant JA, et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb J 2007;21:1647-1654.
83. Grimm J, Kircher ME, Weissleder R. [Cell tracking : Principles and applications.]. Radiologe 2007;47:25-33.
84. Yang PF, Hua TC, Tsung HC, Cheng QK, Cao YL. Effective Cryopreservation of Human Embryonic Stem Cells By Programmed Freezing. Conf Proc IEEE Eng Med Biol Soc 2005;1:482-485.
85. Heng BC, Ye CP, Liu H, Toh WS, Rufaihah AJ, Cao T. Kinetics of cell death of frozen-thawed human embryonic stem cell colonies is reversibly slowed down by exposure to low temperature. Zygote 2006;14:341-348.
86. Attarian H, Feng Z, Buckner CD, MacLeod B, Rowley SD. Long-term cryopreservation of bone marrow for autologous transplantation. Bone Marrow Transplant 1996;17:425-430.
87. Goodwin HS, Grunzinger LM, Regan DM, et al. Long term cryostorage of UC blood units: Ability of the integral segment to confirm both identity and hematopoietic potential. Cytotherapy 2003;5:80-86.
88. Kogler G, Radke TF, Lefort A, et al. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 2005;33:573-583.
89. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006;355:1253-1261.
90. van der Laan LJ, Lockey C, Griffeth BC, et al. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 2000;407:90-94.
91. Nishitai R, Ikai I, Shiotani T, et al. Absence of PERV infection in baboons after transgenic porcine liver perfusion, J Surg Res 2005;124: 45-51.
92. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007;357:2601-2614.
93. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-1751.